Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease
Per Johansson(University of Helsinki), Johan Svensson(National Academy of Medicine), Bo Åhrén(Lund University), Jörgen Isgaard, Niklas Mattsson(Malmö University), Oskar Hansson(Skåne University Hospital), Daniel Åberg(University of Gothenburg), Henrik Zetterberg(National Hospital for Neurology and Neurosurgery), N. David Åberg(Sahlgrenska University Hospital), Anders Wallin(Lund University), Kaj Blennow(Sahlgrenska University Hospital)
Cited by 80
Related Papers
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards
|Stroke|2006|1.7k
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k